RECRUITING

Microdosing ICG for Serial Colonic Perfusion Study During Surgery

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

using microdosing of ICG vs regular dosing of ICG for perfusion assessment during surgery

Official Title

Microdosing ICG for Serial Colonic Perfusion Study During Surgery

Quick Facts

Study Start:2023-11-01
Study Completion:2024-11-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06254833

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * all patient undergoing intestinal resection surgery
  1. * pregnancy, renal insufficiency

Contacts and Locations

Study Contact

Shanglei Liu
CONTACT
(858)249-1837
jtt005@health.ucsd.edu

Study Locations (Sites)

UC San Diego
La Jolla, California, 92093
United States

Collaborators and Investigators

Sponsor: Shanglei Liu

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-01
Study Completion Date2024-11-01

Study Record Updates

Study Start Date2023-11-01
Study Completion Date2024-11-01

Terms related to this study

Additional Relevant MeSH Terms

  • Perfusion; Complications